Patents by Inventor Gopal SAPPARAPU

Gopal SAPPARAPU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTISPECIFIC ANTAGONISTS
    Publication number: 20220389120
    Abstract: Multispecific antagonists for targeting angiogenesis pathways are disclosed. The multispecific antagonists may be used for the treatment of disorders associated with angiogenesis pathways.
    Type: Application
    Filed: June 2, 2022
    Publication date: December 8, 2022
    Inventors: Jackie SHENG, Gopal Sapparapu, Tyler Liban
  • Human monoclonal antibodies to lukab toxin
    Patent number: 10981979
    Abstract: The present disclosure is directed to antibodies binding to prefusion and postfusion forms of both human S. aureus and human metapneumovirus F proteins, including neutralizing antibodies, and methods for use thereof.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: April 20, 2021
    Assignee: VANDERBILT UNIVERSITY
    Inventors: James E. Crowe, Jr., Gopal Sapparapu, Isaac Thomsen, Buddy Creech
  • HUMAN MONOCLONAL ANTIBODIES TO STAPHYLOCOCCUS AUREUS LUKAB TOXIN
    Publication number: 20200010536
    Abstract: The present disclosure is directed to antibodies binding to prefusion and postfusion forms of both human S. aureus and human metapneumovirus F proteins, including neutralizing antibodies, and methods for use thereof.
    Type: Application
    Filed: March 6, 2018
    Publication date: January 9, 2020
    Applicant: Vanderbilt University
    Inventors: James E. CROWE, Jr., Gopal SAPPARAPU, Isaac THOMSEN, Buddy CREECH